welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europe and Japan
Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europe and Japan
expertly curated content related to this topic
-
Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature ReviewPURPOSE : Iron and/or vitamin B12 defici...
-
Sherry C. Huang, MDSherry C. Huang is a board-certified ped...
-
Familial Adenomatous Polyposis (FAP): A Guide for People with FAP and Their Family and FriendsThis Information Guide aims to help you ...
-
How to Defy a Hereditary Predisposition and Prevent Colon Cancerhttps://www.youtube.com/watch?v=IynYbT2i...
-
Celebrex Reduces Polyps Density in Familial Adenomatous Polyposis (FAP)This week in the Orphanet Journal of Rar...
-
Medizinische Hochschule HannoverThe health care center provides people a...
-
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)The purpose of this randomized, double-b...